FindTrial
Sign In

Adenoviral infections in critically ill children

Clinical profile and outcomes of children with adenoviral infection admitted to the Pediatric Intensive Care Unit during an outbreak in Southern India - A multicentric observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085188
Enrollment
200
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B340- Adenovirus infection, unspecified

Interventions

Intervention1: Nil: Nil Control Intervention1: nil: nil

Sponsors

Indian Academy of Pediatrics Intensive Care Chapter Tamil Nadu Puducherry branch
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 1 month and 18 years who were admitted to the PICU with a laboratory-confirmed adenoviral infection from July 2022 to June 2023.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
To determine the clinical outcome in terms of mortality among children aged between 1 month and 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infection.Timepoint: To determine the clinical outcome in terms of mortality among children aged between 1 month and 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infection.—

Secondary

MeasureTime frame
In children aged between 1 month to 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infections: 5. To determine the possible predictors of final clinical outcomesTimepoint: At discharge from PICU;In children aged between 1 month to 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infections: 1. To describe the demographic, clinical, laboratory, & radiological profileTimepoint: At baseline & during PICU stay;In children aged between 1 month to 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infections: 2. To describe the various treatment modalities used & study their association with outcomes Timepoint: At discharge from PICU;In children aged between 1 month to 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infections: 3. To determine the association between co-morbidities & the final outcome, if anyTimepoint: At discharge from PICU;In children aged between 1 month to 18 years admitted to the Pediatric Intensive Care Units with laboratory-confirmed adenoviral infections: 4. To determine the association between other respiratory viral co-infections/secondary bacterial infections & outcomes Timepoint: At discharge from PICU—

Countries

India

Contacts

Public ContactPriyavarthini Venkatachalapathy

Apollo Children s hospital Chennai

drpriyavarthini_v@apollohospitals.com09884278994

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026